Compare Hims and Hers Health Inc (HIMS) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Alliant Energy Corporation — how do they compare? Hims and Hers Health Inc trades at $29.3 (market cap $6.55B), while Alliant Energy Corporation trades at $65.63 (market cap $16.99B). The key difference: Alliant Energy Corporation is far larger — about 2.6× Hims and Hers Health Inc's market cap, and Alliant Energy Corporation pays a 3.27% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Alliant Energy Corporation for 64 Days on average.
| HIMS | LNT | |
|---|---|---|
Market Cap | $6.55B | $16.99B |
Volume | 14,842,814 | 2,488,387 |
Sector | Health | Utilities |
52-Week High | $62.76 | $78.03 |
52-Week Low | $14.52 | $63.21 |
Typical Hold Time | 21 Days | 64 Days |
Enterprise Value | $7.25B | $29.08B |
Dividend Yield | — | 3.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hims & Hers Health (HIMS) trades at $29.38, down 0.54% on the day, amid a bearish technical signal and mixed earnings history. The company reported revenue of $2.35 billion in 2025 with a net income of $128.37 million, but 2026 projections show a net loss of $142 million. Valuation ratios are elevated with a P/E of 57.14 and EV/EBITDA of 205.86. Recent news highlights multiple securities class action lawsuits filed against the company, creating investor uncertainty.
The outlook is cautious due to profitability concerns and legal risks. Analyst consensus is a Hold with a $32.17 price target, suggesting limited upside. Key risks include ongoing litigation, negative profit margins, and high valuation multiples. Investment appeal hinges on the company's ability to return to profitability and navigate regulatory challenges.
LNT trades at $65.21, down 0.43% on the day, with a bullish technical signal despite mixed indicators. The company reported Q2 2026 EPS of $0.65, beating estimates, and maintains a strong profitability profile with an 18.45% net income margin. Recent news highlights institutional buying and a $1.4 billion partnership expansion, though the stock recently touched a 52-week low.
The outlook is supported by a $13.4 billion capital investment plan and data center demand growth, offering potential upside to the $77 consensus price target. Risks include rising debt levels and cost pressures, but analyst sentiment remains positive with no sell ratings. The stock presents a defensive income opportunity with a growing dividend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
